ADRFA Listing of Faculty Publications

Pediatrics Faculty Publication Links
Glen Aylward, Ph.D.
 
Scott Barron, M.D.
 
Dennis T. Crouse, M.D.
 
Mark Fishbein, M.D.
 
Jerie Beth Karkos, M.D.
 
Virginia Kimonis, M.D.
 
Scott S. MacGilvray, M.D.
 
Melissa F. Paoni, Ph.D.
 
Michael Pranzatelli, M.D.
 
Dimitrios Stephanopoulos, M.D.
 
Diane Wildrick
 
ADRFA Faculty Publications Department Listing
 
ADRFA Home Page
 

Pediatrics
Research Publications
1997-2000

Glen Aylward, Ph.D.

  • Books/Tests/Films
    1. Aylward, G.P. (1997). Infant and Early Childhood Neuropsychology (volume in the Child Clinical Library series). New York: Plenum.
    2. Aylward, G.P. (1997). Bayley Infant Neurodevelopmental Screener Prescreening Questionnaire tapes.

  • Journal Articles
    1. Aylward, G.P., Gordon, M., & Verhulst, S.J. (1997). Relationship between continuous performance task scores and other cognitive measures: Causality or commonality?, Assessment, 4, 325-336.
    2. Aylward, G.P. (1997). Conceptual issues in developmental screening and assessment. Journal of Developmental and Behavioral Pediatrics, 18, 340-349.
    3. Aylward, G.P. & Verhulst, S.J.(2000), Predictive utility of the Bayley Infant Neurodevelopmental Screener (BINS) risk status classifications: Interpretation and application. Developmental Medicine & Child Neurology, 42, 25-31.

  • Abstracts
    1. Aylward, G.P., Gordon, M.J., Verhulst, S.J., & Bell, S. Visual and auditory CPTs: Comparison in Clinical and Nonclinical samples. Presented at the Div. 40 (Neuropsychology) program of the 105th Annual Convention of the American Psychological Association, Chicago, IL, Aug. 15-19, 1997.
    2. *Aylward, G.P. Program Faculty. Developmental-Behavioral Disorders and A Spectrum of Pediatric Challenges, Hackensack University Medical Center, Topics: Office Challenges in Developmental Screening and Assessment, The Continuum of Children’s Behavior: Normal, Abnormal or Simply Different. Hilton Head, SC, 5/17-5/23, 1998.
    3. *Aylward, G.P. & Macias, M.M. Problems in developmental/neurodevelopmental screening and assessment. Presented at the “Breakfast with the experts” program, 52nd Annual meeting of the AACPDM, San Antonio, TX, Sept. 16-19, 1998.
    4. Aylward, G.P. Relative risk: Infant neurodevelopmental findings and probabilities of later dysfunction. Presented at the 52nd Annual meeting of the AACPDM, San Antonio, TX, Sept. 16-19, 1998.
    5. Aylward, G.P., & Verhulst, S.J. Neuropsychological findings and relative risk over infancy and early childhood. Presented at the 106th Annual Convention of the American Psychological Association (Division 40, Lifespan Clinical Neuropsychology), San Francisco, CA, Aug. 14-18, 1998.
    6. Aylward, G.P. Alternative risk grouping method for the Bayley Infant Neurodevelopmental Screener (BINS) in prediction of later dysfunction. Presented at the 16th Annual Meeting of the Society for Developmental and Behavioral Pediatrics, Cleveland, OH, Sept. 27-28, 1998.
    7. *Aylward, G.P. Update on developmental screening. Presented at the American Adacemy of Pediatrics 1999 Spring Session, Chicago, IL, April 17-20, 1999.
    8. Aylward, G.P. Continuity of infant neurodevelopmental risk status over the first three years. Presented at the 32nd Annual Gatlinburg Conference on research and theory in mental retardation and developmental disabilities, Charleston, SC, March 18-20, 1999.
    9. *Aylward, G.P. Guest faculty. Thirty-sixth Annual Teaching Conference: Pediatrics for the Practitioner, Dept. of Pediatrics, Univ. of Texas Health Science Center at San Antonio, San Antonio, TX, June 18-20, 1999 (topics: school related issues and the pediatrician, psychopharmacologic management issues, behavioral/psychosocial screening, ADHD).
    10. *Harper, D.C., Aylward, G.P., & Macias, M.D. Autism and PDD: Update on a complex problem. Presented at the 53rd Annual meeting, American Academy for Cerebral Palsy and Developmental Medicine, Washington, DC, Sept. 15-18, 1999.
    11. *Aylward, G.P./Program Faculty. 18th Annual Developmental-Behavioral Disorders and A Spectrum of Pediatric Challenges. Hackensack University Medical Center. Topics: An Office Model for Developmental Screening, and Behavioral Medicine: The Interface Between Psychology and Primary Care, Hilton Head, SC, May 21-24, 2000.
    12. Aylward, G.P., Sunder, T., Lemmon, L., Brager, P., & Rudolph, S. A model for classification of the medical, behavioral, and functional needs of again, developmentally disabled individuals in high-needs residential settings. 33rd Annual Gatlinburg Conference on research and theory in MR and DD. San Diego, CA, March 15-18, 2000.
    13. Aylward, G.P. & Macias, M. A neurodevelopmental prescreening questionnaire for high risk follow-up. To be presented at the 54th Annual Meeting, AACPDM, Toronto, Canada, Sept. 20-23, 2000.

  • Book Chapters
    1. Aylward, G.P. (1997) Environmental influences: Considerations for early assessment and intervention. In S.M.C. Dollinger & L.F. DiLalla (Eds). Intervention and Assessment Across the Life Span, New York: Erlbaum, 9-34.
    2. Aylward, G.P. (2000). Clinical problems of birth, the neonate, and the infant. In C.E. Walker & M.C. Roberts (Eds.), Handbook of Clinical Child Psychology, Third Edition (pp. 245-259), New York: Wiley-Interscience.

  • Book and Test Reviews
    1. Aylward, G.P. Invited test review (1998). Children at Risk Screener: Kindergarten and Preschool. The Thirteenth Mental Measurements Yearbook, Lincoln, NE. Buros Institute of Mental Measurements, University of Nebraska, pp 228-230.
    2. Aylward, G.P. Invited test review (1998). Comprehensive Test of Nonverbal Intelligence. The Thirteenth Mental Measurements Yearbook, Lincoln, NE. Buros Institute of Mental Measurements, University of Nebraska, pp 310-312.
    3. Aylward, G.P. Invited Test Review: Clinical Observations of Motor and Postural Skills. Mental Measurements Yearbook, Lincoln, NE. Buros Institute of Mental Measurements, University of Nebraska (in press).
    4. Aylward, G.P. Invited test review. High/Scope Child Observation Record For Ages 2 ½ - 6. Mental Measurements Yearbook, Lincoln, NE. Buros Institute of Mental Measurements, University of Nebraska (in press).
    5. Aylward, G.P. (1999), Book review. C.R. Reynolds & E. Fletcher-Janzen, Handbook of Clinical Child Neuropsychology (2nd ed.), Journal of Child Clinical Psychology.

  • Other Publications
    1. Aylward, G.P., & Gordon, M.J. (1997). Visual and auditory CPTs: Comparisons across clinical and nonclinical samples. ADHD/Hyperactivity Newsletter, 24, 7-8.
    2. Matula, K., Gyurke, J., & Aylward, G.P. (1997). Response to Commentary on the BSID-II. Journal of Developmental and Behavioral Pediatrics, 18, 112-113.
    3. Aylward, G.P. (1998). Lessons learned in developmental follow-up: The role of environmental influences, Downstate Update, Springfield Perinatal Center, Winter, pp 1-3.

Return to top of page

Scott Barron, M.D.

  • Journal Articles
    1. Scott A. Barron, MD and Edward Spitzmiller, MD, "Gastroesophageal Reflux," Pediatrics in Review: Index of Suspicion, (late 2001).
    2. Scott A. Barron, MD and Thomas Malinich, MD, "Mosaic Down Syndrome," Pediatrics in Review: Index of Suspicion, (March, 2001).
    3. Scott A. Barron, MD, "Weekly Paroxysms of Diffuse Abdominal Pain," in Challenges in Pediatric Diagnosis, Lawrence F. Nazarian, MD, FAAP (Illinois: AAP, 2000), pp. 173-175.
    4. Scott A. Barron, MD, "Leg Pain and Refusal to Walk," in Challenges in Pediatric Diagnosis, Lawrence F. Nazarian, MD, FAAP (Illinois: AAP, 2000), pp. 253-255.
    5. Scott A. Barron, MD, "Henoch-Schonlein Purpura," Pediatrics in Review: Index of Suspicion, 21, No. 2 (Feb., 2000), 67-70.
    6. Scott A. Barron, MD, "Abdominal Migraines," Pediatrics in Review: Index of Suspicion, 20, No. 1 (Jan., 2000), 29-32.
    7. Scott A. Barron, MD, "Oral Exams Over Easy," Contemporary Pediatrics: Clinical Tip, 16, No. 11 (Nov., 1999), 168.
    8. Scott A. Barron, MD, " Catching Earwax Ear-ly," Contemporary Pediatrics: Clinical Tip, 16, No. 8 (Aug., 1999), 144.
    9. Scott A. Barron, MD, "A Better Way to Numb Lacerations," Contemporary Pediatrics: Clinical Tip, 16, No. 3 (March, 1999), 210.
    10. Scott A. Barron, MD, "Try Oil to Foil Ear Pain," Contemporary Pediatrics, Clinical Tip, 16, No. 1, (Jan., 1999), 149.
    11. Scott A. Barron, MD, "Another Scoop in Foreign Bodies," Contemporary Pediatrics: Clinical Tip, 15, No. 10 (Oct., 1998), 222.
    12. Scott A. Barron, MD, "A Chilling Tip for Pain," Contemporary Pediatrics: Clinical Tip, 15, No. 9 (Sep., 1998), 182.
    13. Scott A. Barron, MD, "Charcoal With a Difference," Contemporary Pediatrics: Clinical Tip, 15, No. 8 (Aug., 1998), 161.
    14. Scott A. Barron, MD, "Osteomyelitis," Pediatrics in Review: Index of Suspicion, 19, No. 2 (Feb., 1998), 51-54.
    15. Scott A. Barron, MD, "Vulvovaginitis," Pediatrics in Review: Index of Suspicion, 19, No. 2 (Feb., 1998), 51-54.

Return to top of page

Dennis T. Crouse, M.D.

  • Journal Articles
    1. Neonatal Inhaled Nitric Oxide Study Group: Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. New England Journal of Medicine 336:597-604, 1997.
    2. Pourcyrous M, Korones SB, Crouse D, Bada HS: lnterleukin-6, C-reactive protein, and abnormal cardiorespiratory responses to immunization in premature infants. Pediatrics 101(3):1998.
    3. Crouse DT, English BK, Livingston L, Meals EA: Genital mycoplasmas stimulate tumor necrosis factor- a and inducible nitric oxide synthase production from a murine macrophage cell line. Pediatric Research 44:1-6, 1998.
    4. Talati AJ, Crouse DT, English BK, Newman C, Livingston L, Meals E: Exogenous bovine surfactant suppresses tumor necrosis factor- a release by murine macrophages stimulated by genital mycoplasmas. The Journal of Infectious Diseases 178:1122-1125, 1998.
    5. Mercer BM, Carr TL, Beazley DD, Crouse DT, Sibai BM: Antibiotic use in pregnancy and drug-resistant infant sepsis. American Journal of Obstetrics and Gynecology 181(4):816-21,1999.
    6. Schuchat A, Zywicki SS, Dinsmoor MJ, Mercer B, Romaguera J, O’Sullivan MJ, Patel D, Peters MT, Stoll B, Levine OS, and the Prevention of Early-onset Neonatal Sepsis Study Group: Risk Factors and Opportunities for Prevention of Early-onset Neonatal Sepsis: A Multicenter Case-Control Study. Pediatrics 105(1):21-26,2000.
    7. Renaegar KB, Floyd RA, Krueger JM Crouse DT: Progression of influenza viral infection through the murine respiratory tract: The protective role of sleep deprivation J Sleep and Sleep Disorders Research., accepted for publication June 2000.
    8. Livingston J, Haddad B, Barton J, Park V, Crouse D, Brown K, Quasney M, Sibai B Neither polymorphisms in the tumor necrosis factor alpha gene nor plasma levels are associated with complications of prematurity. J Perinatology, submitted June 2000.

  • Abstracts Published but not Presented
    1. Pourcyrous M, Korones S, Crouse D, Bada H: lnterleukin-6 (IL-6), C-reactive protein (CRP), and cardio respiratory responses to primary routine immunization series in premature infants with bronchopulmonary dysplasia (BPD). Pediatric Research 43(4):251A(#1467), 1998.
    2. Pourcyrous M, Korones S, Crouse D, Bada HS: Interleukin-6 (IL-6), C-reactive protein (CRP), and cardio respiratory responses to primary routine immunization series in premature infants with bronchopulmonary dysplasia (BPD) Pediatric Research 43(4):251A(#1467), 1998.
  • Abstracts Published and Presented
    1. Mercer B (for the NICHD MFMU Network, Bethesda, MD): Maternal and neonatal plasma cytokine levels and perinatal morbidity after preterm PROM, presented before the Society for Gynecologic Investigation Annual Meeting, San Diego, CA, March 1997.
    2. Mercer B (for the NICHD MFMU Network, Bethesda, MD): Maternal and neonatal circulating ICAM-1 for the prediction of perinatal morbidity after preterm PROM, presented before the Society for Gynecologic Investigation Annual Meeting, San Diego, CA, March 1997.
    3. Talati AJ, Crouse DT, English BK, Newman C, Meals E: Suppressive effect of surfactant on TNFa release from murine macrophages stimulated by genital mycoplasmas in normoxia and hyperoxia, presented (A. Talati) before the Society for Pediatric Research, Washington, DC, May 5, 1997. (Poster) Pediatric Research 41(4):227A(#1349), 1997
    4. Talati AJ, Crouse DT, Newman C, English BK, Meals E: Suppressive effect of surfactant on TNFa release from murine macrophages stimulated by live and heat- killed group B streptococci, presented (A. Talati) before the Society for Pediatric Research, Washington, DC, May 5, 1997. (Poster) Pediatric Research 41(4):227A(#1350), 1997.
    5. Pourcyrous M, Korones SB, Crouse D, Bada HS: Interleukin-6 (IL-6) and C-reactive protein (CRP) responses to immunization in premature babies, presented (M. Pourcyrous) before the Society for Pediatric Research, Washington, DC, May 5, 1997. (Poster) Pediatric Research 41(4): 170A(#l007), 1997.
    6. Talati AJ, Crouse DT, English BK, Newman C, Meals E: Surfactant suppresses chemiluminescence activity and TNFa release from murine macrophages stimulated by Group B streptococci, presented (A. Talati) before the Southern Society for Pediatric Research, New Orleans, LA, Feb. 8, 1998. Journal of Investigative Medicine 46(l): 41A, 1998.
    7. Crouse DT, Gandhi R, Causey KT, English BK, Newman C, Meals E: Effect of dexamethasone on TNF alpha and inducible nitric oxide synthase (iNOS) production from mycoplasma-stimulated macrophages, presented before the Pediatric Academic Societies, New Orleans, LA, May 4, 1998. (Poster) Pediatric Research 43(4):245A(#1432), 1998.
    8. Talati AJ, Crouse DT, English BK, Newman C, Meals E, Livingston L: Effect of surfactant phospholipid on TNF alpha release and chemiluminescence activity of stimulated murine macrophages, presented (A. Talati) before the Pediatric Academic Societies, New Orleans, LA, May 4, 1998. (Poster) Pediatric Research 43(4):253A(#1483), 1998.
    9. Crouse DT, Livingston L, Newman C, Talati A, English BK: Antibiotic effect on mycoplasmal-induced chemiluminescence, presented (D. Crouse) before the 12 th International Organization of Mycoplasmology Conference, July 22-28, 1 998. (Poster) Program and Abstracts of 12th International Organization of Mycoplasmology Conference, p. 90 (#B.13), 1998.
    10. Crouse DT, Gandhi R, Causey KT, English BK, Newman C, Livingston L, Meals E: Dexamethasone effect on TNF alpha and inducible nitric oxide synthase (iNOS) production from mycoplasma-stimulated macrophages, presented (D. Crouse) before the 12th International Organization of Mycoplasmology Conference, July 22-28, 1998. (Poster) Program and Abstracts of 12th International Organization of Mycoplasmology Conference, p. 218 (#G.59), 1998.
    11. Talati A, Crouse DT, English BK, Newman C, Livingston L: Effect of dipalmitoyl diphosphatidyl choline (DPPC) on TNF alpha and free oxygen radical release from mycoplasma-stimulated murine macrophages, presented (D. Crouse) before the 12th International Organization of Mycoplasmology Conference, July 22-28, 1998. (Poster) Program and Abstracts of 12th International Organization of Mycoplasmology Conference, p. 218 (#G. 60), 1998.
  • Other Publications
    1. Crouse DT, Huffman DG Tocolytics: What are we doing and why?: Downstate Update, A Publication of the Perinatal Center of Central Illinois, Springfield, Illinois.
    2. Shoukih T, Wilson J, O’Donnell J, English BK, Crouse D, Zhang Q, Quasney MW: Febrile bacteremic children have higher serum levels of TNF-a and IL-6 than febrile nonbacteremic children. Pediatric Emergency Care, submitted July 2000.
    3. Talati AJ, Crouse DT, English BK, Newman C, Harrison L, Meals E: Immunomodulation by exogenous surfactant: Effect on TNFa secretion and luminol-enhanced chemiluminescence activity by murine macrophages stimulated with group B streptococci. Microbes and Infection, submitted, June 2000.
Return to top of page

Mark Fishbein, M.D.

  • Peer Reviewed Journal Articles
    1. Fishbein MH. “A Rapid MRI Technique for the Assessment of Hepatic Steatosis in a Subject with MCAD Deficiency”. Journal of Pediatric Gastroenterology and Nutrition. August, 1998, 27:224-227.
    2. Fishbein MH, Lugo R, Woodland J, Lininger B, Linscheid T. Evaluation of Intranasal Midazolam in Children Undergoing Esophagogastroduodenoscopy. Journal of Pediatric Gastroenterology and Nutrition, 1997, Vol 25, pp 261-266.
    3. Fishbein MH, Long F, Smith M. Fast Gradient Echo MR Imaging of the Liver Enhanced With Superparamagnetic Iron Oxide. Magnetic Resonance Imaging, 1997, Volume 15(6), pp 651-655.
    4. Fishbein MH, Potter C, Gardner K, Schmalbrock P, Smith M. Introduction of Fast MR Imaging in the Assessment of Hepatic Steatosis. Magnetic Resonance Imaging, 1997, Vol 15(3), pp 287-293.
  • Reviews of Abstracts
    1. Gorsline R, Nagita A, Kien CL, McClung HJ, Fishbein MH. Simple Method for Determination of Cytosolic Leucine Aminopeptidase Activity in Serum and Liver With Leucine Hydrazide as Substrate. (Gastroenterology, 1997)
    2. Fishbein MH, Potter C, Gemma S, Smith M, et al. Essential Fatty Acid and Oxidant-Antioxidant Status in CF Subjects With Fatty Liver. (Gastroenterology, 1997)
  • Editorship of Journals
    1. Reviewer for Journal of North American Society for Pediatric Gastroenterology and Nutrition and Journal of Pediatrics
Return to top of page

Jerie Beth Karkos, M.D.
  • Peer Reviewed Journal Articles
    1. Downey and Darling (ed.) Physiologic Basis of Rehabilitation Medicine, “Growth and Development,” Kerstin Sobus and Jerie Beth Karkos, Butterworth Heineman, MA (in print) October 1999
Return to top of page

Virginia Kimonis, M.D.

  • Journal Articles
    1. Kimonis VE, Goldstein AM, Yang ML, DiGiovanna JJ, Bale AE, Bale SJ. 1997. Clinical features in 105 cases of Nevoid Basal Cell Carcinoma (NBCC) Syndrome. Am J Med. Genet. 69:299-308.
    2. Jonas R, Kimonis V, Morales A. Possible new autosomal recessive syndrome of partial agenesis of the corpus callosum, pontine hypoplasia, focal white matter changes hypotonia, mental retardation and dysmorphic features. Am J Med Genet. 73:184-188. 1997.
    3. Pulkkinen L, Kimonis V., Xu Y., Spanou E., Uitto J. H Jonas R, Kimonis V, Morales A. Possible new autosomal recessive syndrome of partial agenesis of the corpus callosum, pontine hypoplasia, focal white matter changes hypotonia, mental retardation and dysmorphic features. Am J Med Genet. 73:184-188. 1997.
    4. Pulkkinen L, Kimonis V., Xu Y., Spanou E., Uitto J. Homozygous a6 integrin mutation in junctional epidermolysis bullosa with congenital duodenal atresia. Human Molecular Genetics. 1997. 6:669-674.
    5. M Kovach, JP Lin, S Boyadjiev, K Herman, W Frank, E Jabs, D Gelber, K Campbell, VE Kimonis. Charcot-Marie-Tooth Syndrome and deafness is associated with a unique point mutation in the PMP22 gene. Am. J Hum Genet.1999.64:1580-1593
    6. KS Chen, L Potocki, DE Osterholm, MA Withers, VE Kimonis, AM Summers, WS Meschino, CD Kashork, LG Shaffer, JR Lupski. Molecular mechanisms for duplication 17p11.2- the homolous recombination reciprocal of a common microdeletion syndrome. Nature Genetics. 2000.24:84-87.
    7. VE Kimonis, M Kovach, R Khardori, D Gelber. Clinical features in a unique family with Autosomal Dominant Limb-Girdle Muscular Dystrophy and Paget Disease of Bone. (In print in Genetics in Medicine).
    8. M. C Schneider, Forrester S, Hughes, C, Kimonis V. Mild phenotype associated with tandem duplication of 17p11.2 (In print in Am J Med Genet).

  • ABSTRACTS & PRESENTATIONS
    1. Jonas R, Kimonis V, Morales A. Possible new autosomal recessive syndrome of partial agenesis of the corpus callosum, pontine hypoplasia, focal white matter changes, hypotonia, mental retardation and dysmorphic features. Poster presentation at SPR meeting, Washington, D.C Mar.97
    2. Kimonis V.E, Zelaya B.M, Grange C. Delineation of the clinical and neuroradiological features in a patient with fumarase deficiency. Platform presentation at the 7th International Congress of Inborn Errors of Metabolism, Vienna, Austria May 21-25, 1997.
    3. Kimonis VE, Loew T, MacGilvray S, Astrin K, Desnick R. Severe phenotype in a patient with congenital erythropoietic porphyria associated with the homozygous C73R genotype. Platform presentation at the 7th International Congress of Inborn Errors of Metabolism, Vienna, Austria May 21-25, 1997
    4. Wesson M, Kimonis V. CATCH 22 associated with sacral meningomyelocele in three siblings. Poster presentation at the 4th Joint Clinical Meeting 1997, Fort Lauderdale, Mar 1997.
    5. VE Kimonis, AS Chen, M Kovach, K Herman, W Frank, A Avakian, J-P Lin. Clinical studies and Linkage analysis in a family with autosomal dominant optic atrophy. Poster presentation at the 47th Annual Meeting of the American Society of Human Genetics. Oct 28- Nov. 1, 1997.
    6. Anticipation in a unique family with Charcot-Marie-Tooth Syndrome and deafness: genetic linkage studies and delineation of the clinical, neurological and audiological features. VE Kimonis1, Y. Mhaskar1, S Boydajiev2, K Herman1, M Kovach1 , W Frank3, JP Lin4 , E Arjmand1, D Gelber1, K Campbell1. Platform presentation at the 5th Combined Clinical Genetics Meeting, Los Angeles, CA, March 1, 1998.
    7. V. Kimonis. Triplets in female with classic galactosemia followed by premature ovarian failure. Poster at Annual Meeting Society for Inherited Metabolic Disorders. Asilomar, Pacific Grove, CA. Mar 15-18, 1998.
    8. VE Kimonis, Y. Mhaskar, S Boyadjiev, K Herman, M Kovach, W Frank, JP Lin, D Gelber, K Campbell. Anticipation in a unique family with Charcot-Marie-Tooth Syndrome and deafness: genetic linkage studies and delineation of the clinical, neurological and audiological features. Platform presentation at the 5th Combined Clinical Genetics Meeting, Los Angeles, CA, March 1, 1998.
    9. VE Kimonis, M Kovach, JP Lin, S Boyadjiev, K Campbell, W Frank, L Mazzeo, E Jabs, D Gelber. A unique family with Charcot-Marie-Tooth syndrome, sensorineural deafness, vocal cord palsy and anticipation maps to chromosome 17p11.2-p12. Platform presentation at British Society of Human Genetics Conference, Sept. 28-30, York, UK.
    10. VE Kimonis, K Campbell, K Herman, M Kovach, JP Lin, L Mazzeo, L Hughes, D Gelber. Delineation of an unusual disorder among 32 individuals with Charcot-Marie-Tooth syndrome associated with hearing loss, Adie’s pupil and anticipation. Platform presentation. 48th Annual Meeting of the American Society of Human Genetics, Denver, CO. Oct 27- Oct 31, 1998.
    11. LA Rimer, LL Estabrooks, VE Kimonis. Apparently balanced complex chromosome rearrangement of chromosome 2 and 10 in two generations with variable phenotype. Poster presention. 48th Annual Meeting of the American Society of Human Genetics, Denver, CO. Oct 27- Oct 31, 1998.
    12. MJ Kovach, J-P Lin, Boyadjiev S, K Herman, W Frank, B Llewelleyn, L Rimer, K Campbell, L Mazzeo, EW Jabs, D Gelber, V Kimonis. Linkage analysis of Charcot-Marie-Tooth syndrome and deafness. Poster presention. 48th Annual Meeting of the American Society of Human Genetics, Denver, CO. Oct 27- Oct 31, 1998.
    13. AS Chen, M Kovach, K Herman, W Frank, A Avakian, J-P Lin, VE Kimonis. Autosomal dominant optic atrophy in a central Illinois family links to chromosome 3q28-qter. Poster presention. 48th Annual Meeting of the American Society of Human Genetics, Denver, CO. Oct 27- Oct 31, 1998.
    14. KS Chen, L Potocki, DE Osterholm, MA Withers, VE Kimonis, AM Summers, WS Meschino, CD Kashork, LG Shaffer, JR Lupski. Homologous recombination and unusual crossover involving a repeat gene cluster in 17p11.2 causes both the Smith Magenis deletion syndrome and the reciprocal duplication. Poster presention. 48th Annual Meeting of the American Society of Human Genetics, Denver, CO. Oct 27- Oct 31, 1998.
    15. VE Kimonis, M Kovach , JP Lin, S Boyadjiev, K Campbell, W Frank, L Mazzeo, E Jabs, D Gelber. A unique mutation in the PMP22 gene associated with Charcot-Marie-Tooth syndrome, sensorineural deafness, vocal cord palsy and anticipation. Platform presentation the American College of Medical Genetics Annual Meeting, Miami, Florida. March 19-21, 1999
    16. Audiologic Findings in Ten Family Members with Charcot-Marie-Tooth Disease with Deafness. Campbell K, Kimonis, V and Mazzeo L. Platform presentation. Auditory Neuropathy Conference, Los Angeles, CA. Mar. 30-31, 1999.
    17. Herman K, Kimonis VE, Kovach M, Campbell K, and Gelber D. Case report: Two individuals with fatal Dejerine-Sottas syndrome in a family with autosomal dominant Charcot-Marie-Tooth Syndrome, Deafness and Anticipation. Alpha Omega Alpha Student Award Presentation, Research Seminar, Southern Illinois University School of Medicine, Springfield, IL. Apr. 14, 1999.
    18. Campbell K, Mazzeo L, Hughes L, Kimonis, V Audiologic Findings in a large family with Charcot-Marie-Tooth Disease and Deafness. Twenty-Second Midwinter Research in Otolaryngology. Feb 13-18th, 1999.
    19. AS Chen, MJ Kovach, VE Kimonis. Neurological and dysmorphic features in a family with brachial plexus neuropathy. Poster presentation. 49th Annual Meeting of the American Society of Human Genetics, San Francisco, CA Oct 19-Oct 23, 1999.
    20. S Forrester, S Rothert, R Urban Jr., MJ Kovach, VE Kimonis. Clinical Features of Four Males and an Obligate Carrier in a Family with Lenz Syndrome. Poster presentation. 49th Annual Meeting of the American Society of Human Genetics, San Francisco, CA Oct 19-Oct 23, 1999.
    21. VE Kimonis, M Kovach, R Khardori, D Gelber. Clinical features in a unique family with Autosomal Dominant Limb-Girdle Muscular Dystrophy and Paget Disease of Bone. Poster presentation. 49th Annual Meeting of the American Society of Human Genetics, San Francisco, CA Oct 19-Oct 23, 1999.

Return to top of page

Scott S. MacGilvray, M.D.
  • Journal Articles
    1. La Mear, N, MAC GILVRAY, SS, Myers, TF. Dexamethasone induced myocardial hypertrophy in neonatal rats. Biology of the Neonate, 72(3):175-180, 1997.
    2. MAC GILVRAY, SS, Myers, TF, Thomas, JX Jr. The effects of glucocorticoids on myocardial mass and function in the rat. (manuscript in preparation).
Return to top of page

Melissa F. Paoni, Ph.D.
  • Journal Articles
    1. Paoni, M.F., & Wise, P.S. (1998). Paraprofessionals in the classroom: A handout for teachers. In A.S. Canter & S.A. Carroll (Eds.), Helping children at home and school: Handouts from your school psychologist. Bethesda, MD: The National Association of School Psychologists.
Return to top of page

Michael Pranzatelli, M.D.

  • Journal Articles
    1. Connolly AM, Pestronk A, Shobhna M, Pranzatelli MR, Noetzel MJ. Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues. Journal of Pediatrics 130:878-884, 1997.
    2. Lafreniere RG, Rochefort DL, Chretien N, Rommens JM, Cochius JL, Kalviainen R, Nousiainen U, Patry G, Farrell K, Soderfeldt B, Federico A, Hale BR, Cossio OH, Sorensen T, Pouliot MA, Kmiec T, Uldall P, Janszky J, Pranzatelli MR, Andermann F, Andermann E, Rouleau GA. Unstable insertion in the 5' flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1. Nature Genetics 15: 298-302,1997.
    3. Bespalova IN, Adkins S, Pranzatelli M, Burmeister M. Novel cystatin B mutation and diagnostic PCR assay in Unverricht Lundborg (Baltic) progressive myoclonus epilepsy patient. American Journal of Medical Genetics (Neuropsychiatric Genetics) 74(5): 467-471, 1997.
    4. Bespalova IN, Pranzatelli M, Burmeister M. G to C transversion at a splice acceptor site causes exon skipping in the cystatin B gene. Mutation Research Genomics 382:67-74, 1997.
    5. Pranzatelli MR. Use of 5,6- and 5,7-dihydroxytryptamine to lesion serotonin neurons. In: Kostrzewa RM (ed) Highly selective neurotoxins: Basic and clinical applications. Humana Press, Inc., Totowa, NY, 1997, in press. 1997.
    6. Pranzatelli MR. Myoclonic disorders. I. Diagnosis and pharmacotherapy. Drugs of Today: Timely Topics in Medicine 33 (4):237-250, 1997.
    7. Pranzatelli MR. Myoclonic Disorders. II. Antimyoclonic drug sites and mechanisms of action. Drugs of Today: Timely Topics in Medicine 33 (5):315-324,1997.
    8. Pranzatelli MR. Serotonergic drugs and movement disorders in humans. Drugs of Today: Timely Topics in Medicine 33 (6):379-392, 1997.
    9. Bespalova IN, Adkins S, Malygina NA, Markova ED, Dietrich M, Pranzatelli M, Gospe SM Jr, Burmeister M. Cystatin B mutations in Unverricht-Lundborg progressive myoclonus epilepsy (EPM1) patients: intrafamial instability and genotype/phenotype correlations, 1997.
    10. Pranzatelli MR, Hanin I, Tate E, Kindel G, Bergin A, Brown CM, Habersang P, Habersang R, Mack KJ, Rosenbaum B, Selby KA. Cerebrospinal fluid free choline in movement disorders of pediatric onset. European Journal of Pediatric Neurology 1: 33-39, 1998.
    11. Pranzatelli MR, Huang Y, Tate E, Goldstein DS, Holmes C, Davies H, Kinast M, Lange BM, Schub HS, Shevell MI, Stanford RE. Effect of high dose corticotropin on cerebrospinal fluid monoaminergic neurotransmitters or metabolites in corticotropin-responsive pediatric opsoclonus-myoclonus. Movement Disorders 13:522-528, 1998.
    12. Pranzatelli MR. Central neurological paraneoplastic syndromes. Part 1. Clinical features, pathophysiology, and immunopharmacology. Drugs of Today 34 (5):415-430, 1998.
    13. Pranzatelli MR. Central neurological paraneoplastic syndromes. Part 2. Practical, theoretical, and mechanistic considerations of treatment with drugs and biologicals. Drugs of Today 34(6), 1998.
    14. Pranzatelli MR. Peripheral neurological paraneoplastic syndromes. Drugs of Today 34(7):625-639, 1998.
    15. Tate E, Pranzatelli MR. Unforgettable Faces:Through the Eyes of a Nurse Practitioner. Atheneum Press, 461 pp, 1999.
    16. Pranzatelli MR. A new age of CNS drug delivery. Drug & Market Development 10 (4):129-136, 1999.
    17. Pranzatelli MR. Innovations in drug delivery to the central nervous system. Drugs of Today 35(6):435-448, 1999.
    18. Pranzatelli MR. The new appeal of nicotinic acetylcholine receptors. Drug & Market Development 10(10):346-352,1999.
    19. Pranzatelli MR. Paraneoplastic syndromes: An unsolved murder. Neuroimmunology issue, Seminars in Pediatric Neurology 7(2):118-130, 2000.

Return to top of page

Dimitrios Stephanopoulos, M.D.
  • Journal Articles
    1. 1998, Critical Care Medicine, 26(10) 1744-1748 , “Continuous Intravenous Terbutaline for Pediatric Status Asthmaticus”. D.E. Stephanopoulos, R Monge, KH Schell, P Wyckoff, BM Peterson.
    2. 2000, Critical Care Medicine, Volume 28 (6) 2179-2180 “Dose of Intravenous Infusions of Terbutaline and Salbutamol” Reply to the letter to the Editor #99-0165 D.E. Stephanopoulos, MD, FAAP.

Return to top of page

Diane Wildrick

  • Journal Articles
    1. Intraventricular Hemorrhage and Long-Term Outcome in the Premature Infant, Journal of Neuroscience Nursing , October, 1997.

Return to top of page

Click here to return to the previous page

This page was updated November 27, 2000